Prognostic analysis of hidradenocarcinoma: a SEER-based observational study

References

• Keasbey LE, Hadley GG. Clearcell hidradenoma; report of three cases with widespread metastases. Cancer. 1954;7(5):934–952.
   PubMed Web of Science ®Google Scholar
• Ohta M, Hiramoto M, Fujii M, et al. Nodular hidradenocarcinoma on the scalp of a young woman: case report and review of literature. Dermatol Surg. 2004;30(9):1265–1268.
   PubMed Web of Science ®Google Scholar
• Mehregan AH, Hashimoto K, Rahbari H. Eccrine adenocarcinoma. A clinicopathologic study of 35 cases. Arch Dermatol. 1983;119(2):104–114.
   PubMedGoogle Scholar
• Kazakov DV, Ivan D, Kutzner H, et al. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation. Am J Dermatopathol. 2009;31(3):236–247.
   PubMed Web of Science ®Google Scholar
• Nandeesh BN, Rajalakshmi T. A study of histopathologic spectrum of nodular hidradenoma. Am J Dermatopathol. 2012;34(5):461–470.
   PubMed Web of Science ®Google Scholar
• Toulemonde A, Croue A, Rodien P, et al. Malignant nodular hidradenoma and multiple nodular hidradenomas in a hypogonadic patient. Annales de Dermatologie et de Venereologie. 2006;133(12):1005–1008.
   PubMed Web of Science ®Google Scholar
• Paranjyothi M, Mukunda A. Clear cell hidradenoma: an unusual tumor of the oral cavity. J Oral Maxillofac Pathol. 2013;17(1):136–138.
   PubMedGoogle Scholar
• Wong TY, Suster S, Nogita T, et al. Clear cell eccrine carcinomas of the skin. A clinicopathologic study of nine patients. Cancer. 1994;73(6):1631–1643.
   PubMed Web of Science ®Google Scholar
• Headington JT, Niederhuber JE, Beals TF. Malignant clear cell acrospiroma. Cancer. 1978;41(2):641–647.
   PubMed Web of Science ®Google Scholar
• Mambo NC. The significance of atypical nuclear changes in benign eccrine acrospiromas: a clinical and pathological study of 18 cases. J Cutan Pathol. 1984;11(1):35–44.
   PubMed Web of Science ®Google Scholar
• Stout AP, Cooley SG. Carcinoma of sweat glands. Cancer. 1951;4(3):521–536.
   PubMed Web of Science ®Google Scholar
• Wu H, Elenitsas R. Malignant nodular hidradenoma in a patient with neurofibromatosis type 1: a case report and review of the literature. Cutis. 2001;68(4):273–278.
   PubMed Web of Science ®Google Scholar
• Sajithkumar VI, Mandai S, Rathore PK. Malignant nodular hidradenoma of nose. Indian J Otolaryngol Head Neck Surg. 1999;51(1):76–77.
   PubMedGoogle Scholar
• Maiti T, Somanna S, Devi BI, et al. Malignant nodular hidradenoma of scalp. J Neurosci Rural Pract. 2014;5(4):423–425.
   PubMedGoogle Scholar
• Souvatzidis P, Sbano P, Mandato F, et al. Malignant nodular hidradenoma of the skin: report of seven cases. J Eur Acad Dermatol Venereol. 2008;22(5):549–554.
   PubMed Web of Science ®Google Scholar
• Nazarian RM, Kapur P, Rakheja D, et al. Atypical and malignant hidradenomas: a histological and immunohistochemical study. Mod Pathol. 2009;22(4):600–610.
   PubMed Web of Science ®Google Scholar
• Hernandez-Perez E, Cestoni-Parducci R. Nodular hidradenoma and hidradenocarcinoma. A 10-year review. J Am Acad Dermatol. 1985;12(1 Pt 1):15–20.
   PubMed Web of Science ®Google Scholar
• Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med. 2000;45(1–2):23–41.
   PubMed Web of Science ®Google Scholar
• Ko CJ, Cochran AJ, Eng W, et al. Hidradenocarcinoma: a histological and immunohistochemical study. J Cutan Pathol. 2006;33(11):726–730.
   PubMed Web of Science ®Google Scholar
• Obaidat NA, Alsaad KO, Ghazarian D. Skin adnexal neoplasms-part 2: an approach to tumours of cutaneous sweat glands. J Clin Pathol. 2007;60(2):145–159.
   PubMed Web of Science ®Google Scholar
• Garcia-Bonafe MM, Campins MM, Redecilla PH. Malignant nodular hidradenoma on the scalp: report of a case with fine needle aspiration cytology features and histologic correlation. Acta Cytol. 2009;53(5):576–580.
   PubMed Web of Science ®Google Scholar
• Orlandi RR, Sercarz JA, Doberneck SA, et al. Malignant clear cell hidradenoma of the upper lip. Head Neck. 1994;16(5):443–449.
   PubMed Web of Science ®Google Scholar
• Messing MJ, Richardson MS, Smith MT, et al. Metastatic clear-cell hidradenocarcinoma of the vulva. Gynecol Oncol. 1993;48(2):264–268.
   PubMed Web of Science ®Google Scholar
• Long WP, Dupin C, Levine EA. Recurrent malignant acrospiroma. Treatment by chest wall excision. Dermatol Surg. 1998;24(8):908–912. discussion 911–2.
   PubMed Web of Science ®Google Scholar
• Jouary T, Kaiafa A, Lipinski P, et al. Metastatic hidradenocarcinoma: efficacy of capecitabine. Arch Dermatol. 2006;142(10):1366–1367.
   PubMedGoogle Scholar
• Tolland JP, Brenn T, Guldbakke KK, et al. Mohs micrographic surgery, sentinel lymph node mapping, and estrogen receptor analysis for the treatment of malignant nodular hidradenoma. Dermatol Surg. 2006;32(10):1294–1301.
   PubMed Web of Science ®Google Scholar